C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2002
11/13/2002	CN1379762A Beta substituted metalloprotease inhibitors
11/13/2002	CN1379666A Non-peptide GnRH agents, methods and intermediates for their preparation
11/13/2002	CN1379028A 2 beta-bromopodophyllo hydrazine derivatives
11/12/2002	US6479673 Antiretroviral enantiomeric nucleotide analogs
11/12/2002	US6479659 Improved process and novel intermediates to endothelin receptor antagonists
11/12/2002	US6479536 Benzofuran derivatives, process for the preparation of the same and uses thereof
11/12/2002	US6479531 Gastrin and cholecystokinin receptor ligands
11/12/2002	US6479524 To prolong the thrombin time
11/12/2002	US6479519 Inhibitors of cell adhesion; treatment of asthma or inflammatory bowel disease
11/12/2002	US6479508 Viral polymerase inhibitors
11/12/2002	US6479505 6-arylphenanthridines with PDE-IV inhibiting activity
11/12/2002	US6479497 Compounds having a selective effect at a subgroup of 5-hydroxytryptamine receptors, designated the h5-ht1b receptor
11/12/2002	US6479494 Arylalkanoyl pyridazines
11/12/2002	US6479492 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/12/2002	US6479490 Treatment of diseases characterized by excess th2 cytokines and/ or an excess ige production.
11/12/2002	CA2324959C Phthalimido compounds as intermediates for producing substance p receptor antagonists
11/12/2002	CA2246839C Pharmaceutical compositions containing ampa receptor antagonists for treating dyskineslas associated with dopamine agonist therapy
11/07/2002	WO2002088118A1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
11/07/2002	WO2002088117A2 Method for producing 2-[-5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane
11/07/2002	WO2002088116A1 Coumarin derivative
11/07/2002	WO2002088114A2 Heteroaryl ofefinic azacyclic and heteroaryl acetylenic azacyclic compounds for the treatment of cns disorders
11/07/2002	WO2002088113A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	WO2002088108A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	WO2002088107A1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof
11/07/2002	WO2002088106A2 Cysteine protease inhibitors
11/07/2002	WO2002088101A2 Inhibitors of bace
11/07/2002	WO2002088097A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002	WO2002088096A1 Compounds inhibiting cyclic nucleotide phosphodiesterases, preparation and uses thereof
11/07/2002	WO2002088094A1 2-iminoimidazole derivatives (1)
11/07/2002	WO2002088092A1 2-iminoimidazole derivative (2)
11/07/2002	WO2002088090A2 Pyrazole derived kinase inhibitors
11/07/2002	WO2002088087A1 Novel heterocyclic derivatives
11/07/2002	WO2002088073A1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
11/07/2002	WO2002087584A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
11/07/2002	WO2001042243A3 Protein kinase inhibitors
11/07/2002	US20020165391 Novel spiro compounds
11/07/2002	US20020165264 Aminal diones as potassium channel openers
11/07/2002	US20020165253 Such as N-(4-chlorobenzyl)-8-(4-hydroxybut-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide for treatment against herpes viruse; enzyme inhibitors
11/07/2002	US20020165235 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists
11/07/2002	US20020165234 Selective B3 adrenergic agonists
11/07/2002	US20020165226 Estrogen receptor modulators
11/07/2002	US20020165222 Protease inhibitors
11/07/2002	US20020165218 Mixture of kinase inhibitor and anticancer agents
11/07/2002	US20020165203 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents
11/07/2002	US20020165094 Herbicidal synergistic composition, and method of controlling weeds
11/07/2002	US20020164809 Acid-labile isotope-coded extractant (ALICE) and its use in quantitative mass spectrometric analysis of protein mixtures
11/07/2002	CA2445871A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
11/07/2002	CA2445629A1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
11/07/2002	CA2445568A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002	CA2445357A1 Pyrazole derived kinase inhibitors
11/07/2002	CA2444500A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	CA2444499A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	CA2429001A1 Cysteine protease inhibitors
11/06/2002	EP1254904A1 Novel piperidine compounds and drugs containing the same
11/06/2002	EP1254899A2 Piperazine derivatives and their use as anti-inflammatory agents
11/06/2002	EP1254897A1 Tricyclic compounds
11/06/2002	EP1254895A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
11/06/2002	EP1254661A1 Method for preventing dyskinesias with selective NMDA-Antagonists
11/06/2002	EP1254138A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
11/06/2002	EP1254119A1 Pyrimidine derivatives as selective inhibitors of cox-2
11/06/2002	EP1254118A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/06/2002	EP1254116A1 Alpha v integrin receptor antagonists
11/06/2002	EP1254115A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
11/06/2002	EP1254114A2 Melanocortin receptor agonists and antagonists
11/06/2002	EP1253925A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method
11/06/2002	EP1253924A1 Nitrate salts of antimicrobial agents
11/06/2002	EP1030843A4 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
11/06/2002	EP0993459B1 Compounds useful for inhibition of farnesyl protein transferase
11/06/2002	EP0915853B1 Substituted 3-phenyl pyrazoles
11/06/2002	EP0912559B1 Fused heterocyclic compounds as protein tyrosine kinase inhibitors
11/06/2002	EP0901488B1 2,4-diaminopyrimidine derivatives
11/06/2002	CN1378544A Substituted azoles compounds
11/06/2002	CN1378542A FAB I inhibitors
11/06/2002	CN1378537A 嘧啶衍生物 Pyrimidine derivatives
11/06/2002	CN1378533A Phenoxypropylamine compounds
11/06/2002	CN1378449A Iron chelators and use thereof
11/06/2002	CN1377880A Compound for curing vascular complication, its preparing method and treating use
11/06/2002	CN1093858C Quinoline and quinozoline compounds useful in therapy, particularly in the treatment of begnin prostatic hyperplasia
11/06/2002	CN1093857C New piperazine and piperidine compounds
11/06/2002	CN1093856C Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds
11/05/2002	US6476235 Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
11/05/2002	US6476227 Piperidine derivative and process for preparing the same
11/05/2002	US6476055 5,5-disubstituted thiazolidine derivative pesticides
11/05/2002	US6476054 Cyclic amine modulators of chemokine receptor activity
11/05/2002	US6476040 Processes and intermediates for preparing anti-cancer compounds
11/05/2002	US6476035 Indole and 2,3-dihydroindole derivatives, their preparation and use
11/05/2002	US6476026 Compounds and compositions as protease inhibitors
11/05/2002	US6476023 Aromatic heterocyclic compounds as anti-inflammatory agents
11/05/2002	CA2038029C 1-alkyl-, 1-alkenyl- and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds, a process and intermediates for their preparation and theeir use as medicaments
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002	WO2002086078A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
10/31/2002	WO2002085906A2 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	WO2002085899A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002	WO2002085896A1 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan
10/31/2002	WO2002085895A1 Quinazoline derivatives
10/31/2002	WO2002085894A1 Arylindenopyridines with pde inhibiting activity
10/31/2002	WO2002085893A1 New aziridine derivatives and their preparation methods
10/31/2002	WO2002085891A1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
10/31/2002	WO2002085887A1 Phenyl- and pyridyl-piperidines with tnf activity
10/31/2002	WO2002085885A1 Piperazino-derivatives and their use as pde4 inhibitor

1 ... 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 ... 694